GALECTIN THERAPEUTICS INC Quarterly Nonoperating Income (Expense) in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Galectin Therapeutics Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2010 to Q2 2024.
  • Galectin Therapeutics Inc Nonoperating Income (Expense) for the quarter ending June 30, 2024 was -$1.08M, a 873% decline year-over-year.
  • Galectin Therapeutics Inc Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was -$4.62M, a 161% decline year-over-year.
  • Galectin Therapeutics Inc annual Nonoperating Income (Expense) for 2023 was -$2.99M, a 606% decline from 2022.
  • Galectin Therapeutics Inc annual Nonoperating Income (Expense) for 2022 was -$424K, a 21.8% decline from 2021.
  • Galectin Therapeutics Inc annual Nonoperating Income (Expense) for 2021 was -$348K, a 1557% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$4.62M -$1.08M -$969K -873% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$3.65M -$1.84M -$656K -55.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$2.99M -$436K -$435K -43500% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 -$2.56M -$1.26M -$787K -166% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 -$1.77M -$111K -$160K -327% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$1.61M -$1.19M -$1.19M -39600% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$424K -$1K -$206K -100% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 -$218K -$475K -$199K -72.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$19K $49K +$305K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$324K $3K +$24K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$348K $205K +$225K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 -$573K -$276K -$259K -1524% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$314K -$256K -$244K -2033% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$70K -$21K -$49K -175% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$21K -$20K -$71K -139% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 $50K -$17K -$96K -122% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $146K -$12K -$34K -155% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $180K $28K +$36K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 $144K $51K +$116K Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 $28K $79K +$151K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$123K $22K +$103K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$226K -$8K +$72K +90% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$298K -$65K -$56K -622% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 -$242K -$72K -$78K -1300% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$164K -$81K -$87K -1450% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 -$77K -$80K -$89K -989% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $12K -$9K -$17K -213% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-06
Q3 2017 $29K $6K -$5K -45.5% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 $34K $6K -$6K -50% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $40K $9K -$5K -35.7% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-11
Q4 2016 $45K $8K -$4K -33.3% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-29
Q3 2016 $49K $11K -$1K -8.33% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $50K $12K -$2K -14.3% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 $52K $14K $0 0% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 $52K $12K +$9K +300% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-28
Q3 2015 $43K $12K +$53K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 -$10K $14K +$68K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 -$78K $14K +$280K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 -$358K $3K -$2K -40% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-15
Q3 2014 -$356K -$41K -$44K -1467% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 -$312K -$54K -$57K -1900% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 -$255K -$266K -$271K -5420% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 $16K $5K -$1K -16.7% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-15
Q3 2013 $17K $3K -$204K -98.6% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 $221K $3K -$5K -62.5% Mar 30, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 $226K $5K +$2K +66.7% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-13
Q4 2012 $224K $6K +$2K +50% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-18
Q3 2012 $222K $207K +$202K +4040% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 $20K $8K +$144K Mar 29, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 -$124K $3K +$382K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q4 2011 -$506K $4K Oct 1, 2011 Dec 31, 2011 10-K 2013-03-29
Q3 2011 $5K -$98K -95.1% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q2 2011 -$136K +$168K +55.3% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-10
Q1 2011 -$379K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-11
Q3 2010 $103K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-10
Q2 2010 -$304K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.